Martin F. Lavin
300 Herston Road
Herston, QLD 4029, Australia
Herston, QLD 4029, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 112 publications
Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia.
Journal: International journal of molecular sciences
Published: July 20, 2026
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis.
Journal: EBioMedicine
Published: January 17, 2025
Ataxia Telangiectasia patient-derived neuronal and brain organoid models reveal mitochondrial dysfunction and oxidative stress.
Journal: Neurobiology of disease
Published: April 11, 2024
Generation of Rapid and High-Quality Serum by Recombinant Prothrombin Activator Ecarin (RAPClot™).
Journal: Biomolecules
Published: April 08, 2024
What's Changed in 75 Years of RadRes? - An Australian Perspective on Selected Topics.
Journal: Radiation research
Published: January 31, 2024
Potential Application of Recombinant Snake Prothrombin Activator Ecarin in Blood Diagnostics.
Journal: Biomolecules
Published: October 05, 2022
Snake Venom Hydrogels as a Rapid Hemostatic Agent for Uncontrolled Bleeding.
Journal: Advanced healthcare materials
Published: March 15, 2022
Metabolic Stress and Mitochondrial Dysfunction in Ataxia-Telangiectasia.
Journal: Antioxidants (Basel, Switzerland)
Published: February 15, 2022
The hallmarks of aging in Ataxia-Telangiectasia.
Journal: Ageing research reviews
Published: February 01, 2022
miRNA-34c-5p targets Fra-1 to inhibit pulmonary fibrosis induced by silica through p53 and PTEN/PI3K/Akt signaling pathway.
Journal: Environmental toxicology
Published: January 22, 2022
Last Updated: 09/26/2026